Please Wait
Applying Filters...
menu
    • menu
    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Seralutinib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Gossamer Bio Launches Exchange Offer to Eliminate $120M+ in Debt
    Gossamer Bio Launches Exchange Offer to Eliminate $120M+ in Debt

    18 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-18/gossamer-bio-inc-launches-exchange-offer-and-consent-solicitation-intended-to-eliminate-over-120

    PHARMIWEB
    18 May 2026
    Share Share
    Gossamer Halves Workforce After Failed Hypertension Trial
    Gossamer Halves Workforce After Failed Hypertension Trial

    19 Mar 2026

    // BIOSPACE

    https://www.biospace.com/business/gossamer-nearly-halves-workforce-in-savings-push-after-late-stage-hypertension-fail

    BIOSPACE
    19 Mar 2026
    Share Share
    Gossamer Bio Fails Phase 3 Pulmonary Arterial Hypertension Trial
    Gossamer Bio Fails Phase 3 Pulmonary Arterial Hypertension Trial

    23 Feb 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/gossamer-bio-fails-phase-3-pulmonary-arterial-hypertension-trial-tries-thread-path-market

    FIERCE BIOTECH
    23 Feb 2026
    Share Share
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108468807/en/Gossamer-Bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)
    Gossamer Bio Issues Inducement Grant Per Nasdaq LR 5635(C)(4)

    09 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251209606832/en/Gossamer-Bio-Announces-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635c4

    BUSINESSWIRE
    09 Dec 2025
    Share Share
    Gossamer Bio To Participate In Upcoming Investor Conferences
    Gossamer Bio To Participate In Upcoming Investor Conferences

    24 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251124688603/en/Gossamer-Bio-to-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    24 Nov 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.